LC–MS-based absolute metabolite quantification: application to metabolic flux measurement in trypanosomes by Kim, Dong-Hyun et al.
ORIGINAL ARTICLE
LC–MS-based absolute metabolite quantification: application
to metabolic flux measurement in trypanosomes
Dong-Hyun Kim1,2 • Fiona Achcar1 • Rainer Breitling3 • Karl E. Burgess4 •
Michael P. Barrett1,4
Received: 27 March 2015 / Accepted: 25 June 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Human African trypanosomiasis is a neglected
tropical disease caused by the protozoan parasite, Try-
panosoma brucei. In the mammalian bloodstream, the
trypanosome’s metabolism differs significantly from that of
its host. For example, the parasite relies exclusively on
glycolysis for energy source. Recently, computational and
mathematical models of trypanosome metabolism have
been generated to assist in understanding the parasite
metabolism with the aim of facilitating drug development.
Optimisation of these models requires quantitative infor-
mation, including metabolite concentrations and/or meta-
bolic fluxes that have been hitherto unavailable on a large
scale. Here, we have implemented an LC–MS-based
method that allows large scale quantification of metabolite
levels by using U-13C-labelled E. coli extracts as internal
standards. Known amounts of labelled E. coli extract were
added into the parasite samples, as well as calibration
standards, and used to obtain calibration curves enabling us
to convert intensities into concentrations. This method
allowed us to reliably quantify the changes of 43 intra-
cellular metabolites and 32 extracellular metabolites in the
medium over time. Based on the absolute quantification,
we were able to compute consumption and production
fluxes. These quantitative data can now be used to optimise
computational models of parasite metabolism.
Keywords Trypanosome  LC–MS  Absolute metabolite
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1 Introduction
Human African trypanosomiasis (HAT), also known as
sleeping sickness, is a neglected tropical disease in sub-
Saharan Africa caused by the protozoan parasite Try-
panosoma brucei and transmitted by tsetse flies (Barrett
et al. 2007; Brun et al. 2010). HAT is fatal if untreated, but
currently used trypanocidal drugs are difficult to adminis-
ter, can cause severe side effects and suffer from emerging
parasite resistance (Delespaux and de Koning 2007; Vin-
cent et al. 2012). Therefore, new drugs are urgently
required to treat the disease, and improved knowledge of
the metabolism of the parasite is necessary to facilitate
drug development. Computational models can be used to
guide our analysis of parasite physiology, and they have
been used in understanding T. brucei metabolism, where it
is hoped that they will play a critical role in developing
optimised anti-parasite drugs (Bakker et al. 2010). How-
ever, such models require quantitative measurements,
including data on concentrations and fluxes of metabolites,
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for their optimisation. Such data have so far been collected
on a small scale, targeting individual reactions and
metabolites (Achcar et al. 2013, 2012; Albert et al. 2005;
Bakker et al. 2000, 1997; Kerkhoven et al. 2013), but a full
understanding of parasite physiology would benefit from a
more global quantitative assessment of metabolite
dynamics.
LC–MS-based metabolomic studies enable simultaneous
measurement of multiple small molecules in a biological
system (Theodoridis et al. 2012; Vincent et al. 2012). The
resulting data have been widely used to investigate the
relative changes in intracellular metabolite concentrations
for biomarker discovery (Denery et al. 2010; van der Kloet
et al. 2012). However, a full understanding of cellular
responses requires absolute metabolite concentrations,
which can feed into quantitative computational models of
metabolism.
LC–ESI/MS is a powerful analytical tool for quantifi-
cation and identification of small molecules (metabolites)
by providing retention time and exact molecular weights.
However, it has some disadvantages, including nonlinear
responses due to detector response and matrix effects
(Annesley 2003). This drawback can lead to nonlinear
calibration curves for quantification, so that true levels of
intracellular metabolites are difficult to ascertain (Shi
2003). In addition, variations in instrumental response and
degradation of metabolites of interest during sample
preparation can also result in a biased quantitative result
(Vuckovic 2012). In order to overcome these challenges,
uniformly (U)-13C-labelled isotopomers of metabolites can
be added as internal standards, behaving identically to their
unlabelled equivalents in sample extracts. The demon-
strated fidelity of Orbitrap mass spectrometers for quanti-
fying isotope ratios (Xu et al. 2010) makes them
particularly suitable for this purpose. However, since the
availability of commercial U-13C-labelled isotopomers is
limited and they are often prohibitively expensive, in vivo
synthesis of U-13C-labelled compounds is required using
suitable microorganisms grown in U-13C-labelled glucose-
limited culture media. Absolute intracellular concentrations
of metabolites in a sample can then be calculated by adding
known amounts of U-13C-labelled cell extract prior to the
extraction procedure (Bennett et al. 2009; Mashego et al.
2004). The most suitable method for this isotope ratio-
based MS (IR-MS) technique is to use the same organism
for generating U-13C-labelled cell extracts which can cover
all of intracellular metabolites for absolute quantification
(Mashego et al. 2004; Wu et al. 2005). However, T. brucei
cannot be used for this purpose, as media containing only
glucose as carbon source are not available (Creek et al.
2013); hence, it is not possible to obtain all metabolites
present in the cell in fully labelled form. Furthermore, T.
brucei reaches a relatively low cell density when
cultivated. Consequently, we decided to explore the utility
of U-13C-labelled E. coli extract as an alternative source of
isotope analogues for quantitative analysis of trypanosome
metabolites.
In this paper, we report the first application of the IR-
MS technique using U-13C-labelled E. coli extracts for the
global quantitative analysis of intra- and extra-cellular
metabolite concentrations in trypanosomes. We analyse the
overlap of E. coli and T. brucei metabolomes to demon-
strate the viability of the approach. Furthermore, by mea-
suring absolute concentrations of extracellular metabolites
in spent media, we were able to compute metabolic fluxes.
2 Materials and methods
2.1 Preparation of U-13C-labelled E. coli extract
and calibration standards
E. coli was cultured on 100 % U-13C-labelled glucose and
the labelled metabolites were extracted using existing
sampling procedures (Rabinowitz and Kimball 2007;
Winder et al. 2008). Briefly, E. coli MG1655 was grown in
500 ml of M9 minimal medium which contained the fol-
lowing per litre: 100 ml of 5 9 M9 minimal medium
(33.9 g of Na2HOP4, 15 g of KH2PO4, 2.5 g of NaCl),
1 ml of 1 M MgSO4, 1 ml of 1 M CaCl2, 3 ml of 2 M
(NH4)2SO4 and 5 ml of 20 % U-
13C-labelled glucose at
37 C overnight. The culture was grown up to an optical
density at 600 nm (OD600) of *1.0 and the cells were
centrifuged at 30009g for 10 min. The supernatant was
removed and 8 ml of -48 C acetonitrile/methanol/water
(2:2:1) was added into the cell pellet for quenching meta-
bolism and extracting metabolites. Then, cells were freeze–
thaw extracted (i.e., flash frozen in liquid N2 for 1 min and
thawed at 4 C, then vortexed for 30 s 9 4) and cen-
trifuged at 30009g for 10 min. The supernatant was col-
lected and stored at -80 C prior to analysis. The U-13C-
labelled extract provides a range of U-13C-labelled internal
standards for each intracellular metabolite being investi-
gated. Furthermore, absolute metabolite concentrations
were obtained by adding the same amounts of the labelled
E. coli extract to both cell samples prior to the extraction
procedure and the unlabelled calibration standards.
The calibration standards for the absolute quantification
of metabolites were prepared by diluting main stock solu-
tions of unlabelled compounds obtaining seven concen-
tration points (0.001, 0.01, 0.1, 1, 10, 50 and 100 lM or
0.03, 0.3, 3, 30, 300, 600, 1200 and 3000 lM). The stan-
dard samples were split into five groups according to their
masses (see Supplementary Table S2), so that metabolites
of similar mass do not overlap, and a clear and single peak
of each metabolite in the MS data can be provided for
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calibration curves. Then, the U-13C-labelled E. coli extract
was added to each calibration sample in a 1:4 ratio.
2.2 Parasite growth conditions and metabolite
extraction
For intracellular concentrations, T. brucei wild type strain
427 bloodstream forms were cultured in HMI-9 (Hirumi
et al. 1977) or Creek’s minimal medium (CMM) (Creek
et al. 2013) supplemented with 10 % fetal bovine serum at
37 C, 5 % CO2 2 9 104 cells/ml were seeded in T150
culture flasks and allow them to reach a density of
2 9 106 cells/ml. Appropriate volumes of cell culture were
taken to yield 5 9 107 cells and quenched in EtOH/dry ice
bath as previously described (t’Kindt et al. 2010). Cells
were centrifuged at 12509g for 10 min and then the
growth medium was removed and the cells were washed
with 1 ml of PBS pre-cooled at 4 C. The cell solution was
centrifuged again at 12509g for 5 min and the supernatant
was removed. Metabolites were extracted by adding 100 ll
of chloroform/methanol/water (1:3:1) spiked with the
U-13C-labelled E. coli extract in a 1:4 ratio and mixed
vigorously for 1 h at 4 C. After centrifugation at
13,0009g for 10 min, the supernatant was collected and
stored at -80 C until LC–MS analysis. One pooled
quality control (QC) sample was prepared by mixing all the
samples in order to assess instrument performance. All
samples were prepared in four biological replicates.
For extracellular concentrations, 0.38 9 104 cells/ml
were seeded in 40 ml of CMM or HMI-9 and incubated at
37 C, 5 % CO2 for 57 h. The cells were sampled for
analysis after 0, 7, 24, 31, 48, 51 and 57 h. During the
incubation period, 5 ml of cell culture was taken and cells
were counted. Then, the cell culture was centrifuged at
12509g for 10 min and 10 ll of supernatant (spent med-
ium) was taken for extracellular concentration measure-
ments. The harvested spent medium was extracted by
adding 190 ll of chloroform/methanol/water (1:3:1) spiked
with the U-13C-labelled E. coli extract in a 1:4 ratio and
mixed vigorously, then stored at -80 C prior to analysis.
All samples were prepared in five biological replicates.
2.3 Analytical methodologies
Separations were performed on a Dionex UltiMate 3000
RSLC liquid chromatography system (Dionex, Camberley,
Surrey). Chromatography was carried out using a ZIC-HILIC
or ZIC-pHLIC 150 9 4.6 mm2, 5 lm column (Merck
Sequant) as previously described (Creek et al. 2011). Briefly,
the column was maintained at 30 C and samples were eluted
with a linear gradient from 80 % B to 20 % B over 32 min,
followed by an 8 min wash with 5 % B, and 8 min re-equi-
libration with 80 % B at the flow rate of 300 ll/min. Mobile
phase A was water (0.1 % v/v formic acid) for a ZIC-HILIC or
20 mM ammonium carbonate in water for a ZIC-pHILIC
column and mobile phase B was acetonitrile (0.08 % v/v
formic acid) for a ZIC-HILIC or 100 % acetonitrile for a ZIC-
pHILIC column. The injection volume was 10 ll and samples
were maintained at 4 C. For the MS analysis, an Orbitrap
Exactive (Thermo Fisher Scientific, Hemel Hempstead, UK)
with a HESI-II probe was operated in polarity switching
mode, with the following settings as previously described
(Creek et al. 2011): resolution 50,000, AGC 1 9 106, m/z
range 70–1400, sheath gas 40, auxiliary gas 20, sweep gas 1,
probe temperature 150 C, and capillary temperature 275 C.
For positive mode ionisation: source voltage?4 kV, capillary
voltage ?50 V, tube voltage ?70 kV, skimmer voltage
?20 V. For negative mode ionisation: source voltage
-3.5 kV, capillary voltage -50 V, tube voltage -70 V,
skimmer voltage-20 V. Mass calibration was performed for
each polarity immediately before each analysis batch. The
calibration mass range was extended to cover small metabo-
lites by inclusion of low-mass contaminants with the standard
Thermo calibration mixture masses (below m/z 1400),
C2H6NO2 for positive ion electrospray ionisation (PIESI)
mode (m/z 76.0393) and C3H5O3 for negative ion electrospray
ionisation (NIESI) mode (m/z 89.0244). To enhance calibra-
tion stability, lock-mass correction was also applied to each
analytical run using these ubiquitous low-mass contaminants.
2.4 Data processing and analysis
Raw LC–MS data were processed with XCMS for untar-
geted peak-picking (Tautenhahn et al. 2008) and mzMatch
for peak matching and annotation of related peaks
(Scheltema et al. 2011). Noise filtering and putative
metabolite identification was performed by IDEOM using
the default parameters (Creek et al. 2012). Metabolite
identification was performed by matching accurate masses
and retention times of authentic standards [Level 1
metabolite identification according to the metabolomics
standards initiative (Sumner et al. 2014, 2007)], but when
standards were not available, predicted retention times
were employed, hence these identifications should be
considered as putative (Level 2 identification).
For the extracellular medium quantifications, raw LC–
MS data were processed with mzMatch and mzMatch-ISO
(Chokkathukalam et al. 2013) (see R script in Supple-
mentary File A). The peaks matching accurate mass and
retention time with our calibration standards were then
selected for interpretation.
2.5 Estimation of metabolic fluxes
Among the 192 calibration standards examined, 32 had
sufficiently clear single peaks in the T. brucei extracts, in
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the calibration standard and in the labelled E. coli extracts
to allow absolute quantification. Calibration curves for
these were constructed by calculating the ratio between the
unlabelled U-12C peaks (from the standards) and the
U-13C-labelled peaks (from E. coli). Using these calibra-
tion curves and the U-12C over U-13C ratios calculated
from the spent medium time course (cells grown in CMM
media), absolute concentrations of these 32 metabolites
were calculated (see Sect. 3). Absolute concentrations of
eight metabolites were also quantified in the spent medium
of cells grown in HMI-9 medium for comparison. From
these time courses, production or consumption fluxes could
be estimated, assuming that these fluxes are constant over
time. Supposing exponential growth, Eq. 1 expresses the
cell density as a function of time:
c tð Þ ¼ c0  exp g  tð Þ; ð1Þ
where c0 is the cell density at time t = 0, g is the growth
rate.
Assuming constant consumption/production flux, Eq. 2
describes the concentration of a metabolite m as a function
of time t:
m tð Þ ¼ k  c0
g
 
 exp g tð Þ  1ð Þ þ m0; ð2Þ
where k is the flux and mo is the concentration of
metabolite m at time t = 0. Given Eqs. 1 and 2, the con-
centration of a metabolite m as a function of cell density
can be expressed by Eq. 3:
m tð Þ ¼ a c tð Þ þ b
a ¼ k
g
; b ¼ k  c0
g
þ m0 ð3Þ
Parameters g and c0 were estimated by fitting the equation
to the data using the python package lmfit (http://cars9.
uchicago.edu/software/python/lmfit/) with the parameters g
and c0 bounded below at 0. Similarly, k and m0 were esti-
mated via a and b by fitting Eq. 3. The flux k was then con-
verted from nmol/(h cell) to nmol/(min 108 cells).
3 Results and discussion
3.1 Comparison of the E. coli and T. brucei
metabolomes
The metabolomes of E. coli and T. brucei were investigated
by an untargeted LC–ESI/MS technique to evaluate which
metabolites can be quantified by the IR-MS technique. The
observed chemical compositions of both species are shown
in Fig. 1a, b.
Totals of 460 and 477 metabolites were putatively
identified in E. coli and T. brucei extracts, respectively.
Detected intracellular metabolites were dominated by a few
chemical classes in both species: metabolites predicted to
be related to the metabolism of amino acids (E. coli,
32.2 %; T. brucei, 28.7 %), carbohydrates (E. coli, 10.2 %;
T. brucei, 12.6 %), nucleotides (E. coli, 8.0 %; T. brucei,
7.5 %), and cofactors and vitamins (E. coli, 8.2 %; T.
brucei, 3.6 %). With the exception of compounds which
were not assigned to any specific class of metabolites,
amino acid metabolism-related metabolites were the most
numerous compounds detected in the both extracts, fol-
lowed by compounds involved in carbohydrate metabo-
lism. Of the measured metabolites in the both extracts, 198
metabolites identified by the technique were common, as
shown in Fig. 1c, and thus are potentially amenable to
absolute quantification as described here. Many core
metabolites, such as amino acids, carbohydrates and
nucleotides, were cross-detected in both species, confirm-
ing our ability to investigate central metabolism of try-
panosomes by measuring metabolic fluxes using the IR-MS
technique with easily generated labelled E. coli extracts.
The complete list of the common putative metabolites is
available in Supplementary Table S3.
3.2 Absolute quantitative analysis of intracellular
metabolites in T. brucei using LC–ESI/MS
An absolute quantitative analysis of intra- and extra-cel-
lular metabolites in T. brucei was carried out. To determine
intracellular concentrations of metabolites in the parasite,
sets of calibration standard mixtures of known concentra-
tions added with U-13C-labelled E. coli extract in a 1:4
ratio were analysed by LC–ESI/MS. Calibration curves of
each metabolite containing a minimum of five concentra-
tion points were then obtained by comparison of the ratios
of mass spectral area from unlabelled (M ? 0) and labelled
{M ? (N 9 1.0033)} metabolites, where M is the
monoisotopic mass (12C-) and N is the number of carbon
atoms of the molecule. Coefficients of determination
showed very good linearity of the calibration curves of 43
intracellular metabolites (R2[ 0.99, data not shown).
The absolute concentrations of 43 intracellular
metabolites were determined against the calibration curves.
The concentrations of intracellular metabolites are shown
in Table 1. Of 43 measured intracellular metabolites, L-
alanine was the most abundant compound (21.4 mM—
HMI-9; 32.8 mM—CMM) in the cell extract, followed by
pyruvate (7.2 mM—HMI-9; 7.1 mM—CMM), L-proline
(3.8 mM—HMI-9; 2.7 mM—CMM) and spermidine
(3.5 mM—HMI-9; 4.2 mM—CMM). The total concentra-
tion of the less abundant metabolites (50 % of all
metabolites measured) was only 0.6 mM.
For the validation of our LC–MS-based absolute quan-
tification method, the measured intracellular concentrations
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of amino acids were compared to measurements in Try-
panosoma gambiense and T. brucei reported in Chappell
et al. (1972) and Smith et al. (2009). As can be seen in
Fig. 2, overall, our measurements are matched relatively
well with Chappell et al.: alanine is by far the most
abundant free amino acid in both media as well as in
Chappell et al. representing 49 % of the total free amino
acid pools in HMI-9, 62 % in CMM and 47 % for Chappell
et al. This is also the case in Trypanosoma cruzi (O’Daly
et al. 1983) and Leishmania species (Simon et al. 1983;
Vieira and Ioav Cabantchik 1995). Glutamate, serine and
glycine represent more than 5 % of the free amino acids
pools in all three series of measurements. The main dif-
ference between our measurements and Chappell et al. is
the fraction of proline and asparagine (5–9 % each in
CMM and HMI-9 but low in Chappell et al.) and the
fraction of arginine (about 8 % in Chappell et al. about 2 %
in CMM and HMI-9). However, differences in growth
conditions, species and environments might have caused
these variations, and this could also explain differences
between the measurements reported by Smith et al. and the
results of other studies.
3.3 Metabolic flux measurement using extracellular
concentrations
The measurement of extracellular metabolites excreted
from cells into their growth media or consumed by the cells
(Chong et al. 2009; Kaderbhai et al. 2003; Kim et al. 2010)
can be connected to intracellular flux states (Mo et al.
2009). Therefore, quantitative analysis of extracellular
metabolites in a growth medium can be employed for an
understanding of cellular metabolism and the measurement
of metabolic fluxes of many metabolites which can feed
into quantitative computational models of metabolism.
Extracellular metabolites were sampled with U-13C-la-
belled E. coli extract from the spent media at seven dif-
ferent time points (0, 7, 24, 31, 48, 51 and 57 h) and 32
metabolites were quantified by the IR-MS technique. It was
confirmed in the previous study that no significant changes
in any medium nutrient was observed in cell-free CMM
incubated at 37 C for 56 h (Creek et al. 2013). Extracel-
lular concentrations from different time points are shown in
Supplementary Table S4. Among these 32 metabolites, the
concentrations of seven metabolites do not change over
time in the medium or the variations are too small to allow
flux quantification (see Fig. 3). It was previously shown
that T. brucei lacks an arginase (Vincent et al. 2012), the
enzyme that converts L-arginine to L-ornithine present
notably in Leishmania (Roberts et al. 2004), and that T.
brucei is capable of taking up L-ornithine from the medium
(Vincent et al. 2012). Our results show that significant
amounts of L-ornithine are not consumed in either CMM or
HMI-9. However, assuming that cells require ornithine
only to synthesise putrescine, spermidine and trypanoth-
ione, we can estimate the total concentration of ornithine
required per cell as about 6.7 mM for cells grown in CMM
and 5.2 mM in HMI-9 [using the concentrations of orni-
thine, putrescine and spermidine in Table 1 and the con-
centration of trypanothione (160 lM) measured by
Fig. 1 Comparison of the
measured metabolomes
extracted from E. coli (a) and T.
brucei (b), and total number of
metabolites identified (c). In
total, 460 and 477 metabolites
were putatively identified in E
coli and T. brucei extracts,
respectively, using LC–MS-
based metabolite profiling. 198
metabolites were determined as
common chemical structures
between both species
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(Henderson et al. 1987)]. Given a cell volume of 5.89 ll/
108 cells (Ariyanayagam et al. 2005), the total quantity of
ornithine required per cell is 3.96 9 10-10 lmol in CMM
and 3.07 9 10-10 lmol in HMI-9 and considering the cell
density after 57 h of culture (about 4.6 9 106 cells/ml in
CMM and 5.4 9 106 cells/ml in HMI-9), the total con-
centration of ornithine in the medium would have
decreased by 1.8 lM (1.8 9 10-3 lmol/ml) in CMM and
1.7 lM in HMI-9 after 57 h. This is clearly too small for us
to see, given the variations of our measurement (see
Table 1 The concentrations of
intracellular metabolites in T.
brucei grown in HMI-9 and
CMM
Name Concetration in HMI-9 (lM ± SEM) Concetration in CMM (lM ± SEM)
N-Acetylornithine 0.2 ± 0.1 0.2 ± 0.0
cis-Aconitate 0.3 ± 0.0 0.3 ± 0.0
Adenosine 28.2 ± 2.2 12.2 ± 1.3
S-Adenosylmethionine 38.5 ± 2.9 44.7 ± 1.2
L-Alanine 21439.1 ± 246.8 32754.3 ± 1334.0
4-Aminobutanoate 19.4 ± 1.8 21.5 ± 2.4
L-Arginine 777.8 ± 28.9 1065.8 ± 111.9
L-Asparagine 2886.0 ± 96.2 2595.4 ± 121.8
L-Aspartate 395.0 ± 37.6 609.2 ± 80.2
Citrate 53.8 ± 5.7 57.7 ± 4.0
Fumarate 347.2 ± 44.4 305.0 ± 40.5
L-Glutamate 2769.4 ± 130.8 3502.7 ± 396.3
L-Glutamine 2469.5 ± 220.5 1736.3 ± 111.8
Glycine 3498.8 ± 94.5 2987.6 ± 58.9
L-Histidine 245.5 ± 8.1 238.4 ± 5.5
(R)-2-Hydroxyglutarate 128.6 ± 4.0 109.8 ± 4.7
Hypoxanthine 325.5 ± 31.5 1.4 ± 0.1
L-Isoleucine 299.2 ± 25.1 82.1 ± 10.4
L-Lysine 346.2 ± 40.5 133.2 ± 5.3
(S)-Malate 324.8 ± 36.2 287.2 ± 40.6
L-Methionine 156.9 ± 6.5 112.1 ± 5.6
50-Methylthioadenosine 2.1 ± 0.2 2.3 ± 0.1
Nicotinamide 25.6 ± 2.9 14.5 ± 0.3
L-Ornithine 407.3 ± 25.4 1072.8 ± 58.5
Orotate \0.3 \0.3
2-Oxoglutarate 845.9 ± 35.1 944.3 ± 131.3
Pantothenate 6.7 ± 0.5 0.3 ± 0.1
L-Phenylalanine 131.3 ± 12.0 48.2 ± 3.1
Phenylpyruvate 92.5 ± 3.8 51.1 ± 2.7
3-Phospho-D-glycerate 2251.7 ± 60.7 1101.1 ± 110.8
Phosphoenolpyruvate 52.6 ± 4.0 27.0 ± 2.2
L-Proline 3835.8 ± 277.2 2688.7 ± 177.5
Putrescine 1157.0 ± 23.2 1282.8 ± 29.7
Pyruvate 7147.3 ± 185.3 7092.3 ± 637.5
L-Serine 3066.4 ± 59.6 2931.0 ± 91.2
Spermidine 3490.7 ± 58.0 4203.9 ± 235.4
Succinate 2914.4 ± 148.7 2975.4 ± 198.2
L-Tryptophan 30.9 ± 8.7 12.4 ± 3.5
L-Tyrosine 331.5 ± 21.6 126.0 ± 3.6
UDP-Glucose 915.3 ± 35.6 1126.1 ± 46.5
Uracil 8.9 ± 0.4 6.5 ± 0.6
L-Valine 504.6 ± 30.2 143.4 ± 15.2
Xanthine 439.2 ± 18.0 111.6 ± 38.5
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Fig. 3). This is also likely to be the case for pantothenate,
which is required for coenzyme A biosynthesis.
For 19 metabolites, the time courses were not consistent
with a constant production or consumption (see Fig. 4a, b).
These metabolites are either amino acids (Fig. 4a) or
nucleosides/nucleotides (Fig. 4b; Supplementary Fig-
ure S6). All of these compounds showed a similar pattern:
over the first 31 h, while the cell number is still relatively
Fig. 2 Comparison of the
percentage of each amino acid
in total intracellular amino acid
concentrations in T. brucei to
measurements reported in
Chappell et al. (1972) and Smith
et al. (2009)
Fig. 3 Variations of
concentrations of the
metabolites measured in CMM
(unless otherwise specified) for
which neither consumption nor
production can be established
over 57 h. The measurements
where done in negative mode
unless ‘‘?’’ is specified. Each
type of symbol corresponds to a
biological replicate of the time
course
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low, the concentration of these metabolites increased; after
31 h they either decrease or continue to increase depending
on the metabolite; in none of the cases do they show the
exponential increase that would result from a constant
production rate. It has been shown that T. brucei secretes
numerous proteins, such as enzymes involved in nucleotide
and protein hydrolysis (Geiger et al. 2010; Holzmuller
et al. 2010; Troeberg et al. 1996). Therefore, the concen-
tration increase in the first 31 h is most likely the result of
amino acid and nucleotide released from proteins and
nucleic acids respectively; with low cell density, the rate of
production of these metabolites exceeds their consumption
by the parasites. By 48 h, as the cell density increases and
depending on the metabolite and its concentration: (i) the
metabolite is now consumed more than it is produced,
hence its disappearance from the medium, or (ii) it is
produced more than it is consumed and it appears to
increase (slowly) over time. Some metabolites are also
produced by the parasite and excreted, and hence continue
to increase, albeit at a decreasing rate.
Finally, six metabolites appear to be constantly pro-
duced or consumed and thus show an exponential increase
or decrease over time (see Fig. 5a), allowing quantification
of their production or consumption (see Sect. 2) when cells
a
b
Fig. 4 Concentrations of amino
acids (a) and nucleoside/
nucleotide (b) in CMM medium
(negative mode unless
otherwise specified) over 57 h.
Each type of symbol
corresponds to a biological
replicate of the time course
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are grown in CMM and HMI-9 (see Fig. 5b). Glutamine is
added to the medium both in CMM (1 mM) and HMI-9
(4 mM) and is consumed rapidly (compared to other amino
acids); therefore, any small increase due to peptidase
activity is not significant. Similarly, L-alanine is produced
from pyruvate and excreted rapidly by the cells, hence any
increase due to peptidase action in the medium is not sig-
nificant and fluxes can be estimated. As expected, the
pyruvate production flux is the highest flux measured. This
flux is the same whether cells are grown in CMM or HMI-9
medium. The pyruvate flux we measured in HMI-9 is
substantially higher than the flux reported by Haanstra
et al. (2012). They measured about 370 nmol/(min 108 -
cells) (calculated from the glucose consumption flux and
the pyruvate production to glucose consumption ratio)
whilst we measured 680 ± 47 nmol/(min 108 cells)
despite similar growth rates (see Supplementary Fig-
ure S7). A difference between experiments in which flux
was measured here and the results of Haanstra et al. is the
cell density at the beginning of the time-course, which
might account for the measured differences.
In addition to pyruvate, L-alanine, 2-oxoglutarate, suc-
cinate and glycerate are constantly produced by the cells.
The L-alanine produced has been shown to come primarily
from pyruvate (Creek et al. 2015) via alanine aminotrans-
ferase (Ariyanayagam et al. 2005). Hence the glutamine
consumed is probably used as an amino group donor,
which would explain why in HMI-9 where the alanine
production is higher, the glutamine consumption is also
higher. Each glutamine can donate up to two amino groups
a
b
c
Fig. 5 a Time-courses and fitted fluxes of constantly consumed or
produced metabolites in CMM medium (negative mode). b Fluxes of
constantly consumed or produced metabolites in both CMM and
HMI-9 medium. Each type of symbol corresponds to a biological
replicate of the time course. *p value\ 0.05, ***p value\ 0.001.
c Simplified schematic of the part of bloodstream form T. brucei
metabolism connected to the elements measured in (a), based on
(Creek et al. 2015). Glc6P glucose 6-phosphate, Fru6P fructose
6-phosphate, Fru16BP fructose 1,6-bisphosphate, DHAP dihydroxy-
acetone phosphate, GA3P glyceraldehyde 3-phosphate, Gly3P glyc-
erol 3-phosphate, Gly glycerol, 13BPGA 1,3-
bisphosphoglyceraldehyde, 3PGA 3-phosphoglyceraldehyde, 2PGA
2-phosphoglyceraldehyde, PEP phosphoenolpyruvate, Pyr pyruvate,
Ala L-alanine, Gln L-glutamine, Glu -glutamate, 2Oxog 2-oxoglu-
tarate, 2Oxogm 2-oxoglutaramate, OAA oxaloacetate, Mal malate,
Fum fumarate, Succ succinate, Asp L-aspartate, CarbAsp carbamoyl-
phosphate, CarbAsp N-carbamoyl-L-aspartate, DihydroO dihydrooro-
tate, Orot orotate, O5P orotate 5-phosphate. Reactions 1 hexokinase,
2 phosphoglucose isomerase, 3 phosphofructokinase, 4 aldolase,
5 glycerol 3-phosphate dehydrogenase, 6 glycerol 3-phosphate
dehydrogenase ? trypanosome alternative oxidase, 7 triosephos-
phate isomerase, 8 glyceraldehyde 3-phosphate dehydrogenase,
9 phosphoglycerate kinase, 10 phosphoglycerate mutase, 11 glyc-
erol kinase, 12 enolase, 13 pyruvate kinase, 14 alanine amino-
transferase and glutamine-pyruvate transaminase (Marciano et al.
2009), 15 the labelling pattern of glycerate in (Creek et al. 2015)
shows that it is most likely produced from triose-phosphate from
glycolysis. The exact reaction and enzyme is not known, 16 glu-
taminase, 17 phosphoenolpyruvate carboxykinase, 18 malate dehy-
drogenase, 19 fumarase, 20 succinate dehydrogenase, 21 possible
pathway producing succinate from 2-oxoglutarate. Exact reactions to
be determined in bloodstream form, 22 aspartate aminotransferase,
23 aspartate carbamoyltransferase, 24 dihydroorotase, 25 dihy-
droorotate dehydrogenase, 26 orotate phosphoribosyltransferase,
27 orotidine-50-phosphate decarboxylase; part of this pathway is
localised in the glycosomes, part is in the cytosol and part remains to
be determined
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and other amino acids can also be used as amino group
donors, explaining why alanine production flux can exceed
the glutamine consumption flux. The cells then excrete
either glutamate (see Fig. 4a) or 2-oxoglutarate or possibly
2-oxoglutaramate (annotation of the latter based on exact
mass only). Interestingly, the cells excrete more 2-oxog-
lutarate in CMM than in HMI-9 despite consuming less
glutamine. Two hypotheses could explain such a discrep-
ancy: (i) the cells excrete more glutamate or 2-oxoglu-
taramate in HMI-9, which would mean that in the presence
of more glutamate (4 mM in HMI-9, 1 mM in CMM) the
cells only use one of the two amino groups available in
glutamine, (ii) the cells could further metabolise 2-oxog-
lutarate more in HMI-9. The latter hypothesis is further
strengthened by the tenfold higher rate of production of
succinate in HMI-9 as compared to CMM. Indeed, the
succinate produced has been shown to come only in part
from glucose, the rest most probably coming from amino
acids (Creek et al. 2015). The small amount of glycerate
produced comes from glucose (Creek et al. 2015) and is
similar in both media.
It is worth noting that our measurements of the fluxes of
succinate and alanine production are similar to those
recently measured by Mazet et al. using NMR (Mazet et al.
2013) [1.2 nmol/(min 108 cells) of succinate and 14 nmol/
(min 108 cells) of alanine], although the pyruvate produc-
tion flux that they measured [130 nmol/(min 108 cells) is
significantly lower than that measured here or in Haanstra
et al. (2012], probably due to stressful culture conditions in
Mazet et al. (2013) (5 h in phosphate-buffered saline
solution with added glucose but no other nutrients).
3.4 Metabolites detected in the medium that could
not be absolutely quantified
Supplementary Figure 6 contains the time courses of
metabolites identified in the medium (exact mass and reten-
tion time matching with their standards) that could not be
quantified, either because the metabolite is absent inE. coli or
because the concentration is beyond the dynamic range of our
calibration curve (either in the medium or in E. coli). Among
them, 11 compounds (L-cysteine, phenylpyruvate, imidazole-
4-acetate, hydroxyglutarate, glucuronolactone, glucono-1,4-
lactone, nicotinic acid, thymine and orotate) seem to be con-
stantly produced or consumed. L-cysteine is known to be
consumed in large quantities and is essential to T. brucei
(Creek et al. 2013; Duszenko et al. 1992). Phenylpyruvate is
the keto-acid produced from L-phenylalanine. Similarly,
imidazole 4-acetate might be a degradation product or frag-
ment of imidazole 4-pyruvate, the keto-acid produced from L-
histidine and hydroxyglutarate is the reduced form of 2-ox-
oglutarate, the keto-acid produced from L-glutamate. Indeed,
it has long been known that T. brucei excretes numerous of
these keto-acids (Berger et al. 1996; Creek et al. 2013; Stibbs
and Seed 1973, 1975) that are produced via promiscuous
aminotransferases (Ariyanayagam et al. 2005; Marciano et al.
2008).
Nicotinic acid is consumed by the cells where it is used
in the production of nicotinamide-based cofactors e.g.,
NAD(H) and NADP(H). While it cannot be excluded with
certainty that the detected compound is actually isonico-
tinic acid, based on exact mass and retention time simi-
larity to the nicotinic acid standard, it is here putatively
identified as nicotinic acid, as isonicotinic acid is not
involved in any pathways or reactions documented for
trypanosomes, in contrast to nicotinate which is a part of
the NAD salvage pathway.
Thymine and orotate can be produced via degradation of
nucleotides. They might therefore be expected to be
acquired from medium as we see after 31 h for other
nucleotides. However, since trypanosomes are capable of
synthesising thymine and orotate from glucose (Creek et al.
2015) there is no observed decrease in the medium. Indeed,
for thymine no uptake could be observed (Gudin et al.
2006).
The origin of the increased concentration of carbohy-
drate lactones is assumed to be the oxidation of glucose in
the medium over the time course.
4 Conclusion
We report a practical methodology using an isotope ratio-
based mass spectrometry technique for the measurement of
intra- and extra-cellular concentrations of 43 metabolites in
T. brucei and its spent medium. This study also demon-
strates that the technique is a useful tool for the estimation
of metabolic fluxes of the metabolites, providing an accu-
rate and unbiased method for the analysis of intracellular
metabolism. The computed metabolic fluxes will now
allow us to identify the most plausible metabolic network
topology and drive the extension of the existing computa-
tional models to a more comprehensive representation of
the metabolic capacity of the parasite (Achcar et al. 2014;
Bakker et al. 2010). Importantly, this absolute quantitative
technique can be easily transferred to other organisms that
cannot be grown on glucose as the sole carbon source,
including human cells.
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